Story · Medicine & Biotech
Riyaz Shah: HER2-Directed Therapies for Advanced HER2-Mutant NSCLC
1 outlet · first reported by OncoDaily on
Riyaz Shah, Consultant Medical Oncologist at Cromwell Hospital, shared on LinkedIn: “Lovely analysis in HER2 mutated NSCLC demonstrating that in the absence of H2H data, on balance the TKI’s have (OncoDaily)
Coverage, in order
-
Riyaz Shah: HER2-Directed Therapies for Advanced HER2-Mutant NSCLCRiyaz Shah, Consultant Medical Oncologist at Cromwell Hospital, shared on LinkedIn: “Lovely analysis in HER2 mutated NSCLC demonstrating that in the absence of H2H data, on balance the TKI’s have
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.